RM-581

N/A

Report date: 2025/07/10 11:35:56
NME

Base Information

Drug NameRM-581
Drug Alias NameRM-581
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionendoplasmic reticulum-stress stimulants
TargetsUpdating
Therapy Area/IndicationsProstatic NeoplasmsSmall Cell Lung CarcinomaCarcinoma, Non-Small-Cell Lung +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCentre de recherche du CHU de Québec-Université Laval
China Registration ClassN/A

Develop Information

Active CompaniesNeolys Pharma Inc
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsSmall Cell Lung CarcinomaCarcinoma, Non-Small-Cell Lung +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A